Recombinant soluble trimeric CD40 ligand is biologically active.
about
Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cellsTargeting platelet-derived soluble CD40 ligand: a new treatment strategy for HIV-associated neuroinflammation?Crystallographic and Mutational Analysis of the CD40-CD154 Complex and Its Implications for Receptor ActivationVascular endothelial growth inhibitor (VEGI), an endogenous negative regulator of angiogenesisResveratrol prevents EBV transformation and inhibits the outgrowth of EBV-immortalized human B cellsChronic immune activation in HIV-1 infection contributes to reduced interferon alpha production via enhanced CD40:CD40 ligand interactionUpdate on the hyper immunoglobulin M syndromesPatients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets.A Salmonella typhi OmpC fusion protein expressing the CD154 Trp140-Ser149 amino acid strand binds CD40 and activates a lymphoma B-cell line.Ectopic expression of a truncated CD40L protein from synthetic post-transcriptionally capped RNA in dendritic cells induces high levels of IL-12 secretion.The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells.CD40L and Its Receptors in Atherothrombosis-An UpdateThe soluble CD40 ligand sCD154 in systemic lupus erythematosusVEGI, a new member of the TNF family activates nuclear factor-kappa B and c-Jun N-terminal kinase and modulates cell growth.HIV patients treated with low-dose prednisolone exhibit lower immune activation than untreated patientsCD40 ligand (CD154) and tumour necrosis factor-related apoptosis inducing ligand (Apo-2L) in haematological malignancies.Excess soluble CD40L contributes to blood brain barrier permeability in vivo: implications for HIV-associated neurocognitive disordersSoluble CD40 ligand stimulates CD40-dependent activation of the β2 integrin Mac-1 and protein kinase C zeda (PKCζ) in neutrophils: implications for neutrophil-platelet interactions and neutrophil oxidative burstAntiplatelet activity of valproic acid contributes to decreased soluble CD40 ligand production in HIV type 1-infected individualsTNF superfamily protein-protein interactions: feasibility of small- molecule modulationT lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation.Soluble CD40 ligand contributes to dendritic cell-mediated T-cell dysfunction in HIV-1 infection.Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions.CD40 ligation induces tissue factor expression in human vascular smooth muscle cells.Reduced pathology following infection with transgenic Leishmania major expressing murine CD40 ligand.Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis.Anti-CD 40 monoclonal antibody.Titratable Avidity Reduction Enhances Affinity Discrimination in Mammalian Cellular Selections of Yeast-Displayed Ligands.Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo.Increased synthesis of anti-tuberculous glycolipid immunoglobulin G (IgG) and IgA with cavity formation in patients with pulmonary tuberculosis.The promiscuous protein binding ability of erythrosine B studied by metachromasy (metachromasia).Functional CD40 ligand is expressed by T cells in rheumatoid arthritis.TNF and TNF receptor superfamily members in HIV infection: new cellular targets for therapy?Molecular mechanism and function of CD40/CD40L engagement in the immune system.Tuning of CD40-CD154 interactions in human B-lymphocyte activation: a broad array of in vitro models for a complex in vivo situation.Adjuvants for enhancing the immunogenicity of whole tumor cell vaccines.Incorporation of native antibodies and Fc-fusion proteins on DNA nanostructures via a modular conjugation strategy.A factor of inducing IgE from a filarial parasite is an agonist of human CD40.Circulating CD40 and sCD40L Predict Changes in Renal Function in Subjects with Chronic Kidney Disease.CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway.
P2860
Q24563090-52B01B5D-25AC-4556-B16B-287AFC96EB2EQ27010594-3BE9DACE-1CDA-439A-A6FF-93126A6E90C1Q27666816-802EEF5B-5DCD-49DB-9FEB-35BCA965DE65Q28300434-C32B79FA-9686-4378-88BA-A6FD25B24D54Q28484266-50331AF8-53E2-4253-8125-3496BD31C793Q28731004-71552D68-23AF-43DC-969C-86D577146D5AQ28972255-FE350ADD-6449-453A-B174-C3EF8C36D647Q33183129-85356670-826A-4E27-8219-70FEC397E9DDQ33193416-97FB956E-4BC4-4B1A-B8D1-61E1C2538AD7Q33377577-2215D39D-67CB-4B69-8C66-FAF9E5D51674Q33711057-EA18692F-8329-46C0-AB07-07101DE8AEC3Q33814059-F857FB4D-C172-4A1C-A81E-218B6D839BA1Q33858548-CFAA1330-B228-4C11-90DC-7A069E862EE2Q33883558-3745306D-BA7B-4B12-99C5-269D4367C970Q34134411-D7D7F46B-F02C-44B3-9B12-BB47E49B5BE8Q34266298-E04F5D0D-0524-42F2-9419-0CB51675E736Q34517239-3EFF970A-CCA2-480D-8E49-3E155C2085D5Q34778615-FDA3388B-C17D-45F0-BAED-27C2C6051E07Q35131181-035943B2-FBA9-4B21-9584-FEB74F673480Q35534271-A6441663-B583-4CD5-B9AA-EA5F89FB369EQ35754623-BDA75912-01E5-4C29-8854-63E11FFE752CQ35772650-F03EC053-E989-43F3-B818-61448ACFF2B3Q35788328-296974C9-888C-47E8-AF25-9DB9EEF1DE17Q35793488-0E0C5809-F788-4E46-9DA8-491A02A1F379Q35913436-B3D04FB7-FD27-4FAC-AB4C-CB4F04B6D571Q36028683-B61F0F4C-C307-4402-B6E2-2CBC0DBF60F9Q36221538-9B9F5C35-0AF8-4E2D-AC80-6D01C9784493Q36316025-914F25B1-9F71-426E-B688-D7DD26D55363Q36367835-B0326570-ACAB-47BB-A594-63DF51B32F72Q36497627-EB788EDC-0B8D-4ACB-A515-0C533D61E32CQ36745762-906E7DAF-0BDA-4AEC-AF24-73DD0EB2A143Q37374541-7FDF2099-BA3A-48B0-8D06-760F4F79B8B4Q37433321-8B378E63-80C5-4066-A554-5A1795DC469CQ37474929-E2610F79-7BB1-45EB-8B5E-CCB9D58ABA98Q37828473-E47872D1-3BD0-47C4-9022-2A4B18FCCCC2Q37873932-CF97A4E6-797A-4E52-9EEA-19EBFD127620Q38287944-1D14B20E-0ACF-4750-BD94-BFFEB2FBA9C3Q38295976-063DF768-38A1-4A35-9550-36D41CEFC389Q38628139-F19F0496-39B2-49FD-89B2-C2EBCDD5EE2EQ39311520-852A5D26-CA49-4FEA-8D8C-95404AF0E68D
P2860
Recombinant soluble trimeric CD40 ligand is biologically active.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Recombinant soluble trimeric CD40 ligand is biologically active.
@en
type
label
Recombinant soluble trimeric CD40 ligand is biologically active.
@en
prefLabel
Recombinant soluble trimeric CD40 ligand is biologically active.
@en
P2093
P2860
P356
P1476
Recombinant soluble trimeric CD40 ligand is biologically active.
@en
P2093
Bonnefoy JY
Edgerton MD
Gauchat JF
Lecoanet-Henchoz S
Losberger C
P2860
P304
P356
10.1074/JBC.270.13.7025
P407
P50
P577
1995-03-01T00:00:00Z